GSK — GSK PLC

Ownership history in Caitlin John, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Caitlin John, LLC reported a position in GSK PLC (GSK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 2 — 0% 0.00% $86 $42.44
2024 Q4 UNCHANGED 2 — 0% 0.00% $68 $32.17
2024 Q3 UNCHANGED 2 — 0% 0.00% $70 $38.44
2023 Q4 INITIATED 2 — — 0.00% $75 —
% of Fund (quarterly)    GSK price (monthly, adj. close)

Other funds also holding GSK

As of 2025 Q4 — sorted by position size

Eversept Partners, LP 3Y 7Y 6.62% Mondrian Investment Partners LTD 3Y 7Y 4.7% EQUITY INVESTMENT CORP 3Y 7Y 4.07% Callodine Capital Management, LP 3Y 7Y 3.96% Hillman Capital Management, Inc. 3Y 7Y 3.53% KEATING INVESTMENT COUNSELORS INC 3Y 7Y 2.45% MILLER HOWARD INVESTMENTS INC /NY 3Y 7Y 2.43% Clean Yield Group 3Y 7Y 2.2% NIA IMPACT ADVISORS, LLC 3Y 2.08% Altrius Capital Management Inc 3Y 2.05%
← Back to Caitlin John, LLC Holdings